ECG detection of left ventricular hypertrophy

Gosse, Philippe; Jan, Emilie; Coulon, Paul; Crémer, Antoine; Papaioannou, Georgios; Yeim, Sunthareth

doi:10.1097/hjh.0b013e3283524961

Cited by 43 publications

(33 citation statements)

References 19 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…28 Office BP was measured with an oscillometric device (Omron M6 Comfort), and the mean of the last 2 of 3 determinations after 5-minute rest was recorded. 29 and heart rhythm disorders. Regarding kidney function, a single-spot urine sample was collected and sent to central laboratory for albumin-to-creatinine ratio determination.…”

Section: Clinical Data Collection and Physical Examinationmentioning

confidence: 99%

Prevalence and Associated Factors of Silent Brain Infarcts in a Mediterranean Cohort of Hypertensives

et al. 2014

View full text Add to dashboard Cite

show abstract

Section: Clinical Data Collection and Physical Examinationmentioning

confidence: 99%

Prevalence and Associated Factors of Silent Brain Infarcts in a Mediterranean Cohort of Hypertensives

et al. 2014

View full text Add to dashboard Cite

show abstract

“…15 In the past few years, several new ECG parameters have been proposed for improving detection of LV dysfunction and hypertrophy. These parameters, which include the time interval between the peak and the end of the T wave (Tp-Te interval), 16 ventricular activation time (VAT), 17 and the P-wave analysis, 18 have been demonstrated to be related to increased LVM, LV diastolic dysfunction, and risk of cardiac arrhythmias in several clinical settings other than hypertension.…”

Section: 2mentioning

confidence: 99%

A Novel Electrocardiographic T‐Wave Measurement (Tp‐Te Interval) as a Predictor of Heart Abnormalities in Hypertension: A New Opportunity for First‐Line Electrocardiographic Evaluation

Ferrucci¹,

Canichella²,

Battistoni³

et al. 2015

J of Clinical Hypertension

View full text Add to dashboard Cite

The aim of the study was to evaluate the role of conventional and new markers of early cardiac organ damage (OD) on 12-lead electrocardiography (ECG) Global cardiovascular risk assessment represents a fundamental step in the clinical management of hypertension.1,2 Beyond proper measurement of clinic blood pressure (BP) levels, current European guidelines strongly recommend including a thorough assessment of markers of hypertension-related organ damage (OD) at cardiac, renal, and vascular levels.3 Systematic search of OD has been demonstrated to be useful for the daily clinical management of hypertensive patients by: (1) ameliorating individual global cardiovascular risk stratification; (2) improving patients' own awareness of an asymptomatic disease; and (3) helping physicians choose the best diagnostic and therapeutic options. 1,2Presence of OD, in fact, may suggest the use of select antihypertensive drug classes or molecules, which have been demonstrated to confer proven benefits in favoring prevention and promoting regression of markers of OD, beyond their BP-lowering efficacy. 4,5 At the cardiac level, hypertension-related OD is characterized by an increased left ventricular mass (LVM), leading to the development of left ventricular hypertrophy (LVH) and increased risk of major cardiovascular events.6-10 LVH can be detected on conventional 12-lead electrocardiography (ECG) using Sokolow-Lyon and Cornell indexes. 11,12 Even in the presence of high sensitivity; however, the diagnostic ability of ECG is blunted by its relatively low specificity, which may induce false-negative results. To overcome this intrinsic limitation and to improve early detection of LVH in a setting of clinical practice, even in the asymptomatic stages of hypertension, a larger use for echocardiography has been proposed over the years. 13,14 This method has the advantage of providing more accurate estimation of LVM and LV geometry with both high sensitivity and specificity for LVH detection. Even in this case, however, the relatively high cost of the procedure as well as the need for adequate user expertise have limited the applicability of echocardiographic estimation of LVH to the general population of hypertensive patients. 3 Other advanced diagnostic procedures, eg, computed tomography or magnetic resonance for LVM assessment, have limited applicability in the daily clinical practice of hypertension because of high cost and reduced availability in some hospital divisions and hypertension excellence centers.The primary role of conventional 12-lead ECG has recently been reaffirmed in the first-line diagnostic workup of hypertension to estimate presence of cardiac OD. 15 In the past few years, several new ECG parameters have been proposed for improving detection of LV dysfunction and hypertrophy. These parameters, which include the time interval between the peak and the end of the T wave (Tp-Te interval), 16 ventricular activation time (VAT), 17 and the P-wave analysis, 18 have been demonstrated to be related to increased LVM, LV dias...

show abstract

“…The recent guidelines of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC) [12] and the Italian Joint Guidelines of the Società Italiana dell'Ipertensione Arteriosa (SIIA), the Società Italiana di Cardiologia (SIC) and Associazione Nazionale Medici Cardiologi Ospedalieri (ANMCO) [13] stated that a 12-lead electrocardiogram (ECG) should be part of the routine assessment of all hypertensive patients. The ECG has a low sensitivity in detecting LVH, although is reproducible, has a high specificity and low costs [14]. Echocardiography is considered among the recommended techniques to be considered in hypertensive patients before starting antihypertensive therapy, but also during treatment.…”

Section: Definitionmentioning

confidence: 99%

Echocardiography in Hypertension

Cuspidi

Luca

Muiesan

2013

High Blood Press Cardiovasc Prev

View full text Add to dashboard Cite

show abstract

ECG detection of left ventricular hypertrophy

Abstract: In the interpretation of an ECG in the hypertensive patient, the single measurement of the R wave in aVL gives results at least as good as those of more complicated indices, which do not appear to contribute further to the diagnosis of LVH and the prediction of cardiovascular risk.

Cited by 43 publications

References 19 publications

Prevalence and Associated Factors of Silent Brain Infarcts in a Mediterranean Cohort of Hypertensives

Prevalence and Associated Factors of Silent Brain Infarcts in a Mediterranean Cohort of Hypertensives

A Novel Electrocardiographic T‐Wave Measurement (Tp‐Te Interval) as a Predictor of Heart Abnormalities in Hypertension: A New Opportunity for First‐Line Electrocardiographic Evaluation

Echocardiography in Hypertension

Contact Info

Product

Resources

About